Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

BACKGROUND: Sarcopenia is known to be related to an increased risk of chemotherapy toxicity and to a poor prognosis in patients with malignancy. We assessed the prognostic role of sarcopenia in patients with diffuse large B‐cell lymphoma (DLBCL). METHODS: In total, 187 consecutive patients with DLBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Go, Se‐Il, Park, Mi Jung, Song, Haa‐Na, Kim, Hoon‐Gu, Kang, Myoung Hee, Lee, Hyang Rae, Kim, Yire, Kim, Rock Bum, Lee, Soon Il, Lee, Gyeong‐Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833756/
https://www.ncbi.nlm.nih.gov/pubmed/27104110
http://dx.doi.org/10.1002/jcsm.12115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833756/
https://www.ncbi.nlm.nih.gov/pubmed/27104110
http://dx.doi.org/10.1002/jcsm.12115

Ejemplares similares